For research teamsHelp me find a study
Back to all studies
CompletedNCT02139111

PRC-063 for ADHD

This study is completed in the United States and in Canada. It is testing PRC-063 for ADHD.

ADHDDrugFrom 12 Years to 17 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether PRC-063 may be useful for adolescents experiencing ADHD.

What would participation involve?

Participants may receive PRC-063, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Canada and in the United States.

Who is it mainly for?

This study appears to be mainly for adolescents with ADHD. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateApril 2014
Recruitment status
Completed
Enrollment listed in the registry
360
Sponsor
Rhodes Pharmaceuticals, L.P.
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Canada
Age range
From 12 Years to 17 Years
Official registry ID
NCT02139111
Official title
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02139111. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Canada · 12 sites
  • Mathison Centre for Mental Health Research and Education
    Calgary, Alberta
    Site status: Not listed — confirm with the team
  • University of Calgary
    Calgary, Alberta
    Site status: Not listed — confirm with the team
  • Chokka Center for Integrative Health
    Edmonton, Alberta
    Site status: Not listed — confirm with the team
  • Dr. Margaret Weiss
    Vancouver, British Columbia
    Site status: Not listed — confirm with the team
  • Atlantic ADHD Centre
    Dartmouth, Nova Scotia
    Site status: Not listed — confirm with the team
  • McMaster University
    Hamilton, Ontario
    Site status: Not listed — confirm with the team
  • Doctors Jackiewicz Professional Medical Corporation
    Niagra Falls, Ontario
    Site status: Not listed — confirm with the team
  • Dr. Judy van Stralen
    Ottawa, Ontario
    Site status: Not listed — confirm with the team
  • Stress, Trauma, Anxiety, Rehabilitation and Treatment (START) in the Mood and Anxiety Disorders Clinic
    Toronto, Ontario
    Site status: Not listed — confirm with the team
  • The Kids Clinic
    Whitby, Ontario
    Site status: Not listed — confirm with the team
  • McGill University Health Centre
    Montreal, Quebec
    Site status: Not listed — confirm with the team
  • Royal University Hospital Saskatoon
    Saskatoon, Saskatchewan
    Site status: Not listed — confirm with the team
United States · 31 sites
  • UCLA
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Synergy Clinical Research
    National City, California
    Site status: Not listed — confirm with the team
  • Newport Beach Clinical Research Associates, Inc.
    Newport Beach, California
    Site status: Not listed — confirm with the team
  • Orange County Neuro Phychiatry Research Centre
    Orange, California
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Research
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • CNS Healthcare Jacksonville
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center
    Maitlin, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Miami Research Associates
    South Miami, Florida
    Site status: Not listed — confirm with the team
  • Stedman Clinical Trials
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Advanced Clinical Research
    Boise, Idaho
    Site status: Not listed — confirm with the team
  • Kennedy Krieger Institute
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • Center for Psychiatry and Behavioral Medicine Inc.
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Duke University Medical Center
    Durham, North Carolina
    Site status: Not listed — confirm with the team
  • Wake Research Associates
    Raleigh, North Carolina
    Site status: Not listed — confirm with the team
  • University of Cincinnati
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • IPS Research Company
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions Inc.
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • FutureSearch Clinical Trials, L.P.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • FutureSearch Trials of Dallas, L.P.
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Bayou City Research Ltd
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Red Oak Psychiatry Associates
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Houston Clinical Trials
    Houston, Texas
    Site status: Not listed — confirm with the team
  • The University of Texas Health Science Center at San Antonio
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Ericksen Research
    Clinton, Utah
    Site status: Not listed — confirm with the team
  • Physiciatric and Behavioral Solutions
    Salt Lake City, Utah
    Site status: Not listed — confirm with the team
  • NeuroScience
    Herndon, Virginia
    Site status: Not listed — confirm with the team
  • Northwest Clinical Research Center
    Friday Harbor, Washington
    Site status: Not listed — confirm with the team
  • Eastside Therapeutic Resource
    Kirkland, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo, PRC-063 25 mg, PRC-063 45 mg, PRC-063 70 mg, PRC-063 85 mg. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with adhd; age range: From 12 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Rhodes Pharmaceuticals, L.P., which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.